SDPS-10 DISPARITIES IN THE RISK OF CNS METASTASIS AND CLINICAL OUTCOMES IN PATIENTS WITH HER2- MUTATION POSITIVE (HER2+) NON-BREAST VERSUS HER2+ BREAST CANCERS

BACKGROUND: Risk of CNS metastases is well characterized for patients (pts) with HER2+ breast cancer (BC), however, poorly defined for pts with HER2+ non-breast solid tumors (ST). METHODS: We performed a retrospective cohort analysis to characterize the frequency of CNS metastasis and clinical outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Elghawy, Omar, Horton, Bethany, Shen, Shiyi, Kaur, Varinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Screening/Diagnostics/Prognostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402440/
http://dx.doi.org/10.1093/noajnl/vdad070.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402440/
http://dx.doi.org/10.1093/noajnl/vdad070.070

Ejemplares similares